Participant flow

Dalteparin in Preventing DVT in Participants With Cancer · Source last updated 2021-01-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Received dalteparin 5000 units daily postop, patients with metastatic disease.

   id

   FG000

   title

   Interventional (Dalteparin, Metastatic)

2. description

   Received dalteparin 5000 units daily postop, patients with primary sarcomas.

   id

   FG001

   title

   Interventional (Dalteparin, Sarcoma)

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         25

      2. group Id

         FG001

         num Subjects

         25

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         25

      2. group Id

         FG001

         num Subjects

         25

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

A total of 65 participants enrolled into the trial. 15 participants did not meet entry criteria and were excluded.

recruitment Details

Recruitment Period: July 2006 - December 2010

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice